Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 86663

Qualitative or semiquantitative immunoassay for Epstein-Barr (EB) virus, early antigen (EA) antibodies.

Use 86663 for multi-step qualitative or semiquantitative immunoassays. For single-step methods, use 86318. For quantitative tests, use 86317. Report one unit per EBV EA type or immunoglobulin class. When reporting multiple units, check payer guidelines for modifier use (e.g., 91, 59).

Modifiers 91 (repeat test) and 59 (distinct procedural service) may be applicable, depending on payer guidelines and the specific clinical circumstances.

Medical necessity is established by the patient's clinical presentation and suspicion of EBV infection, especially when initial testing is inconclusive.

The lab analyst performs the technical steps of the immunoassay, including reacting the specimen, incubation, adding detection agents, and interpreting the results.

In simple words: This test checks your blood for signs of a past or current infection with the Epstein-Barr virus (EBV), which can cause mono (infectious mononucleosis) and other illnesses. It's especially helpful when other tests for EBV are negative but you have symptoms.

This code represents a multi-step qualitative or semiquantitative immunoassay performed to detect antibodies to early antigen (EA) of the Epstein-Barr virus (EBV) in a patient's serum. The test helps diagnose EBV infections, including infectious mononucleosis, particularly in symptomatic patients with negative heterophile antibody tests. It is also used in pregnant women and immunocompromised individuals. The procedure involves reacting the specimen with test antigens, incubating the mixture, adding a detection agent (stain, fluorescent marker, etc.), and interpreting the results (positive, negative, or semi-quantitative value).

Example 1: A patient presents with symptoms of infectious mononucleosis (fatigue, fever, sore throat) but tests negative for heterophile antibodies. The 86663 test is ordered to further investigate the possibility of EBV infection., A pregnant woman exhibits symptoms similar to infectious mononucleosis. The 86663 test, as part of a larger panel, aids in differentiating between EBV infection and other conditions with similar symptoms., An immunocompromised patient requires an assessment of prior EBV exposure. The 86663 test is performed to determine the presence of EBV EA antibodies.

Documentation should include the patient's symptoms, reason for testing (e.g., suspected EBV infection, negative heterophile antibody test), and the type of immunoassay performed.

** This code is specific for the detection of antibodies to EBV early antigen (EA). It does not cover antigen detection. Specimen collection (e.g., venipuncture) may be billed separately.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.